AstraZeneca–Bristol Myers Squibb Merger Talks: Is the $400 Billion Pharma Deal Confirmed?
AstraZeneca and Bristol Myers Squibb are reportedly exploring a combination that could create a pharmaceutical group worth close to $400 billion. The possibility has immediate implications for AZN and BMY…

















